• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

DRRX:US

1.5200 USD 0.0200 1.33%

As of 17:20:00 ET on 07/29/2014.

Snapshot for Durect Corp (DRRX)

Open: 1.5000 Day's Range: 1.4800 - 1.5200 Volume: 333,170
Previous Close: 1.5000 52wk Range: 1.0000 - 2.6900 1-Yr Rtn: +19.69%

Stock Chart for DRRX

No chart data available.
  • DRRX:US 1.5100
  • 1D
  • 1M
  • 1Y
1.5000
Interactive DRRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DRRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.1900
Est. EPS (USD) (12/2014) -0.0300
Est. PEG Ratio -
Market Cap (M USD) 165.78
Shares Outstanding (M) 110.52
30 Day Average Volume 367,908
Price/Book (mrq) 5.6631
Price/Sale (ttm) 9.2249
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DRRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DRRX

Durect Corporation develops and commercializes pharmaceutical systems for the treatment of chronic diseases. The pharmaceutical systems provide therapy for chronic diseases or conditions by replacing multiple injection therapy or oral dosing, improving drug efficacy, reducing side effects, and ensuring dosing compliance.

Felix TheeuwesChairman/Chief Scientific OfcrJames E BrownPresident/CEO/Co-Founder
Matthew J HoganChief Financial OfficerSu Il YumExec VP:Pharmaceutical Sys
More Company Profile & Key Executives for DRRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil